Showing 1341-1350 of 20878 results for "".
- Arcutis Reports Positive Phase 2 Data for Infant Atopic Dermatitis Programhttps://reachmd.com/news/arcutis-reports-positive-phase-2-data-for-infant-atopic-dermatitis-program/2485557/Arcutis Biotherapeutics reported positive topline results from the phase 2 INTEGUMENT-INFANT trial evaluating investigational ZORYVE® (roflumilast) cream 0.05% in infants aged 3 months to younger than 24 months with mild to moderate atopic dermatitis (AD).
- Revolutionizing Cancer Therapy: The Impact of Macrophage-Targeting Immunotherapyhttps://reachmd.com/news/revolutionizing-cancer-therapy-the-impact-of-macrophage-targeting-immunotherapy/2485523/Mount Sinai researchers developed a macrophage-targeting immunotherapy —
- Rethinking Support for Breastfeeding: Addressing Trauma to Improve Outcomeshttps://reachmd.com/news/rethinking-support-for-breastfeeding-addressing-trauma-to-improve-outcomes/2485528/A recent narrative review finds that prior psychological trauma is associated with lower breastfeeding initiation and shorter duration, and emphasizes the importance of p
- Telesurgery vs. Robotic Surgery: Innovations in Urologic Oncologyhttps://reachmd.com/news/telesurgery-vs-robotic-surgery-innovations-in-urologic-oncology/2485531/A randomized, multicenter non-inferiority trial found remote telesurgery to be non-inferior to local robotic surgery for radical prostatectomy and partial nephrec
- Intralesional Cemiplimab Shows High Pathologic Response in Early-Stage CSCChttps://reachmd.com/news/intralesional-cemiplimab-shows-high-pathologic-response-in-early-stage-cscc/2485540/Low-dose intralesional cemiplimab produced high objective and pathologic response rates without treatment-limiting toxicity in patients with early-stage cutaneous squamous cell carcinoma (CSCC), according to “Intralesional Cemiplimab for Patients With Early-Stage Cutaneous Squamous Cell Carcinoma
- Candela Launches Glacē™ System at IMCAS Paris, Expands Portfolio with Matrix™ and Vbeam® Prohttps://reachmd.com/news/candela-launches-glace-system-at-imcas-paris-expands-portfolio-with-matrix-and-vbeam-pro/2485539/Candela debuted its latest innovation, the Glacē™ System, during the 2026 IMCAS World Congress in Paris, marking the European launch of a platform designed to elevate facial skin treatments across aesthetic and medical settings. The system, which offers both standalone and adjunctive skin purific
- Therapeutic Inertia in Lipid Management: Overcoming Barriers in Primary Carehttps://reachmd.com/news/therapeutic-inertia-in-lipid-management-overcoming-barriers-in-primary-care/2485502/A recent narrative review shows that many at-risk patients remain above LDL‑C targets despite clear evidence that cumulative LDL‑C exposure increases cardiovascular event risk. Therapeutic inert
- The Impact of Social Media on Adolescent Mental Health: Clinical Considerations for Pediatric Practicehttps://reachmd.com/news/the-impact-of-social-media-on-adolescent-mental-health-clinical-considerations-for-pediatric-practice/2485500/New evidence links social media exposure with rising anxiety, depression, and suicidal ideation among adole
- Phase 1 Trial Explores FMT–ICI Combination in mRCChttps://reachmd.com/news/phase-1-trial-explores-fmtici-combination-in-mrcc/2485507/A phase 1 clinical trial has reported that fecal microbiota transplantation (FMT) from healthy donors, when administered alongside immune checkpoint inhibitors (ICIs), was safe and potentially associa
- Daily Beef Consumption: Impact on Prediabetes Risk Factorshttps://reachmd.com/news/daily-beef-consumption-impact-on-prediabetes-risk-factors/2485489/A randomized crossover trial in adults with prediabetes tested daily intake of 6–7 ounces cooked beef and found no change in glycemic or cardiome